Extracellular vesicles from obese and diabetic mouse plasma alter C2C12 myotube glucose uptake and gene expression

• Published in: Physiological reports Vol. 12; no. 1; pp. e15898 - n/a
• Main Authors: Pitzer, Christopher R., Paez, Hector G., Ferrandi, Peter J., Mohamed, Junaith S., Alway, Stephen E.
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.01.2024; John Wiley and Sons Inc; Wiley
• Subjects: Animals; Antibiotics; Body fat; Cell culture; Culture media; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - metabolism; Extracellular vesicles; Extracellular Vesicles - metabolism; Gene Expression; Genotype & phenotype; Glucose; Glucose - metabolism; Homeostasis; Insulin resistance; Isoforms; Lipid metabolism; Lipids; Metabolism; Mice; muscle; Muscle Fibers, Skeletal - metabolism; Musculoskeletal system; Myosin; Myosin Heavy Chains - genetics; Myosin Heavy Chains - metabolism; Myotubes; Obesity; Obesity - metabolism; Original; Oxidation; Phenotypes; Phosphorylation; RNA, Messenger - metabolism; Skeletal muscle; type 2 diabetes; metabolism; extracellular vesicles; type 2 diabetes; obesity; muscle
• ISSN: 2051-817X; 2051-817X
• DOI: 10.14814/phy2.15898

Recent studies have indicated a role for circulating extracellular vesicles (EVs) in the pathogenesis of multiple diseases. However, most in vitro studies have used variable and arbitrary doses of EVs rather than interpreting EVs as an existing component of standard skeletal muscle cell culture media. The current study provides an initial investigation into the effects of circulating EVs on the metabolic phenotype of C2C12 myotubes by replacing EVs from fetal bovine serum with circulating EVs from control mice or mice with obesity and type 2 diabetes (OT2D). We report that EVs associated with OT2D decrease 2‐NBDG uptake (a proxy measure of glucose uptake) in the insulin‐stimulated state compared to controls. OT2D associated EV treatment also significantly decreased myosin heavy chain type 1 (MHCI) mRNA abundance in myotubes but had no effect on mRNA expression of any other myosin heavy chain isoforms. OT2D‐associated circulating EVs also significantly increased lipid accumulation within myotubes without altering the expression of a selection of genes important for lipid entry, synthesis, or catabolism. The data indicate that, in a severely diabetic state, circulating EVs may contribute to insulin resistance and alter gene expression in myotubes in a manner consistent with the skeletal muscle phenotype observed in OT2D.